Cite
HARVARD Citation
Hummel, J. et al. (2022). Eight weeks of empagliflozin does not affect pancreatic fat content and insulin secretion in people with prediabetes. Diabetes, obesity & metabolism. 24 (8), pp. 1661-1666. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hummel, J. et al. (2022). Eight weeks of empagliflozin does not affect pancreatic fat content and insulin secretion in people with prediabetes. Diabetes, obesity & metabolism. 24 (8), pp. 1661-1666. [Online].